Company

YGION Biomedical

Biotechnology Research Vienna, At 12 employees

Employees: 12
Contacts: 4
Emails: 4

www.ygion.bio LinkedIn Crunchbase

YGION Biomedical Overview

Headquarters: Vienna, At
Website: www.ygion.bio
Industry: Biotechnology Research
Employees: 12
Founded: 2022
Funding: 16.3M
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Immunooncology Personalized Medicine Neoepitopes Oncology Immunotherapy

About YGION Biomedical

YGION Biomedical is an Austrian biotechnology company, dedicated to make individualized cancer immunotherapy a reality. By applying groundbreaking, innovative technologies, we strive to provide better and more effective treatments to cancer patients. Our approach encompasses a targeted activation of the patient’s immune system, promising to elicit a fast, strong, and long-lasting specific immune response with an excellent safety profile. We believe that directing the patient’s immune system specifically against the tumor will provide an opportunity for long-term protection against tumor relapse and metastasis and thus will contribute to an improved success for the treatment of cancer.

YGION Biomedical Contact Details

People in AeroLeads: 4
With contact data: 4
Email contacts: 4; 100.0% coverage

YGION Biomedical Org Chart

Sample employees and titles

Name	Title	Location	Contact
Alexander Seitz	Managing Director Adranos Invest Gmbh	Austria	Email
Wolfgang Fischl	CEO & Co-founder at Ygion Biomedical	Vienna, Austria	Email
Georg Casari	COO at Ygion Biomedical	Austria	Email
Gottfried Himmler		Austria	Email